Follow up results of a prospective study to evaluate the impact of FDG-PET on CT- based radiotherapy treatment planning for oesophageal cancer  Sweet Ping.

Slides:



Advertisements
Similar presentations
Neoadjuvant twice daily chemoradiotherapy for esophageal cancer: Treatment-related mortality and long-term outcomes  Stuart E. Samuels, MD, PhD, Matthew.
Advertisements

Nicoletta Colombo, Martin Gore 
The Use of Hormone Therapy Alone Versus Hormone Therapy and Radiation Therapy for Breast Cancer in Elderly Women: A Population-Based Study  Alan M. Nichol,
A Royal College of Radiologists National Audit of Radiotherapy in the Treatment of Metastatic Spinal Cord Compression and Implications for the Development.
18Fluorodeoxyglucose PET Is Prognostic of Progression-Free and Overall Survival in Locally Advanced Pancreas Cancer Treated With Stereotactic Radiotherapy 
Close or Positive Margins After Mastectomy for DCIS: Pattern of Relapse and Potential Indications for Radiotherapy  Afshin Rashtian, M.D., Shawn Iganej,
Radiotherapy for Postoperative Thoracic Lymph Node Recurrence of Non–Small-Cell Lung Cancer Provides Better Outcomes If the Disease Is Asymptomatic and.
Using low-dose radiation to potentiate the effect of induction chemotherapy in head and neck cancer: Results of a prospective phase 2 trial  Susanne M.
Higher-Than-Conventional Radiation Doses in Localized Prostate Cancer Treatment: A Meta-analysis of Randomized, Controlled Trials  Gustavo Arruda Viani,
The dose–response of salvage radiotherapy following radical prostatectomy: A systematic review and meta-analysis  Christopher R. King  Radiotherapy and.
SYSTEMS-2: A randomised phase II study of radiotherapy dose escalation for pain control in malignant pleural mesothelioma  M. Ashton, N. O'Rourke, N.
Volume 74, Issue 4, Pages (October 2018)
Jennifer C. Ho, MD, Quynh-Nhu Nguyen, MD, Heng Li, PhD, Pamela K
Improved outcome of treating locally advanced lung cancer with the use of Lattice Radiotherapy (LRT): A case report  Beatriz E. Amendola, Naipy C. Perez,
Local control and overall survival after frameless radiosurgery: A single center experience  Angelika Bilger, Florian Frenzel, Oliver Oehlke, Rolf Wiehle,
Role of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non–Small Cell Lung Cancer in a Prospective Nationwide Oncology Outcomes Database  Alex.
Clinical and Translational Radiation Oncology
Waleed Brinjikji, MD, Jennifer M. Boland Froemming, MD, William P
Radiotherapy for Postoperative Thoracic Lymph Node Recurrence of Non–Small-Cell Lung Cancer Provides Better Outcomes If the Disease Is Asymptomatic and.
Prospective Assessment of Patient-Rated Symptoms Following Whole Brain Radiotherapy for Brain Metastases  Edward Chow, MBBS, Lori Davis, PhD, Lori Holden,
Volume 148, Issue 1, Pages (January 2018)
Volume 61, Issue 6, Pages (June 2012)
Pain in cancer survivors; filling in the gaps
Role of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non–Small Cell Lung Cancer in a Prospective Nationwide Oncology Outcomes Database  Alex.
Physics and Imaging in Radiation Oncology
Salvage Lung Resection After Definitive Radiation (>59 Gy) for Non-Small Cell Lung Cancer: Surgical and Oncologic Outcomes  Julie E. Bauman, MD, Michael.
Patient-reported symptoms and performance status before palliative radiotherapy in geriatric cancer patients (octogenarians)  Carsten Nieder, Thomas A.
Surgery vs. primary radiotherapy in early-stage oropharyngeal cancer
Role of radiotherapy in extracranial metastatic malignant melanoma in the modern era  Ryan S. Youland, Miran L. Blanchard, Roxanna Dronca, Lisa Kottschade,
Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J
Emma Hedin, Anna Bäck, Roumiana Chakarova 
Leukocytosis, prognosis biomarker in locally advanced head and neck cancer patients after chemoradiotherapy  Antoine Schernberg, Pierre Blanchard, Cyrus.
PARADIGM-2: Two parallel phase I studies of olaparib and radiotherapy or olaparib and radiotherapy plus temozolomide in patients with newly diagnosed.
Improved Overall Survival with Aggressive Primary Tumor Radiotherapy for Patients with Metastatic Esophageal Cancer  David M. Guttmann, MD, MTR, Nandita.
Axillary radiotherapy for nodal lymphoma: What CTV expansion is required to account for absence of pre-chemotherapy treatment position FDG PET-CT?  Robin.
Clinical and Translational Radiation Oncology
Successful immunotherapy and irradiation in a HIV-positive patient with metastatic Merkel cell carcinoma  Annett Linge, Ricarda Rauschenberg, Sophia Blum,
Gross tumour delineation on computed tomography and positron emission tomography- computed tomography in oesophageal cancer: A nationwide study  M.E. Nowee,
Jeffrey Bradley, MD, Issam El Naqa, PhD  Journal of Thoracic Oncology 
Survival and failure types after radiation therapy of vulvar cancer
Evaluating the prevalence and predictive factors of vasomotor and psychological symptoms in prostate cancer patients receiving hormonal therapy: Results.
Age-not Charlson Co-morbidity Index-predicts for mortality after stereotactic ablative radiotherapy for medically inoperable stage I non-small cell lung.
Volume 5, Issue 7, Pages (July 2008)
Concurrent chemotherapy and intensity modulated radiation therapy in the treatment of anal cancer: A retrospective review from a large academic center 
Impact of waiting time on nodal staging in head and neck squamous-cell carcinoma treated with radical intensity modulated radiotherapy  Cédric Chevalier,
Cone-Beam CT-based position verification for oesophageal cancer: Evaluation of registration methods and anatomical changes during radiotherapy  A. van.
Study of diffusion weighted MRI as a predictive biomarker of response during radiotherapy for high and intermediate risk squamous cell cancer of the oropharynx:
Jean-Emmanuel Bibault, Ingeborg Tinhofer 
What is the impact of diabetes mellitus on radiation induced acute proctitis after radical radiotherapy for adenocarcinoma prostate? A prospective longitudinal.
Re-evaluation of the Role of Postoperative Radiotherapy and the Impact of Radiation Dose for Non–Small-Cell Lung Cancer Using the National Cancer Database 
Daniel Morgensztern, MD, Boone Goodgame, MD, Maria Q
Grant G. Altobelli, Toshifumi Kudo, MD, PhD, Bradley T. Haas, Fiona A
Clinical and radiobiological evaluation of a method for planning target volume generation dependent on organ-at-risk exclusions in magnetic resonance.
Impact of a Multidisciplinary Thoracic Oncology Clinic on the Timeliness of Care  Richard F. Riedel, MD, Xiaofei Wang, PhD, Meg McCormack, PA-C, Eric Toloza,
Prognostic impact of leukocyte counts before and during radiotherapy for oropharyngeal cancer  Garrett L. Jensen, Pierre Blanchard, G. Brandon Gunn, Adam.
Sites of recurrent disease and prognostic factors in SCLC patients treated with radiochemotherapy  Rebecca Bütof, Calogero Gumina, Chiara Valentini, Antje.
Telehealth in radiation oncology at the Townsville Cancer Centre: Service evaluation and patient satisfaction  Elizabeth Hamilton, Ellie Van Veldhuizen,
Rectal volume variations and estimated rectal dose during 8 weeks of image-guided radical 3D conformal external beam radiotherapy for prostate cancer 
Plasma proteins as prognostic biomarkers in radiotherapy treated head and neck cancer patients  Line Brøndum, Jesper Grau Eriksen, Brita Singers Sørensen,
High Frequency of Radiation Pneumonitis in Patients with Locally Advanced Non-small Cell Lung Cancer Treated with Concurrent Radiotherapy and Gemcitabine.
Medical Treatment of Overactive Bladder: In Response
Aisling Krishnan, Yat Man Tsang, Adéle Stewart-Lord 
A Phase II Study of Carboplatin, Etoposide, and Exisulind in Patients with Extensive Small Cell Lung Cancer: CALGB 30104  Ramaswamy Govindan, MD, Xiaofei.
Radiation dose mapping and anastomotic complications after trimodality therapy for esophageal cancers  Andrew Bang, Joel A. Broomfield, Jessica Chan,
Patterns of practice in palliative radiotherapy for bleeding tumours in the Netherlands; a survey study among radiation oncologists  Jennifer Strijbos,
Management of Mediastinal Relapse after Treatment with Stereotactic Body Radiotherapy or Accelerated Hypofractionated Radiotherapy for Stage I/II Non–Small-
Volume 54, Issue 1, Pages (July 2008)
APLCC POSTER SESSION 2 - WEDNESDAY, NOVEMBER 28
Clinical and Translational Radiation Oncology
Volume 154, Issue 1, Pages (July 2019)
Presentation transcript:

Follow up results of a prospective study to evaluate the impact of FDG-PET on CT- based radiotherapy treatment planning for oesophageal cancer  Sweet Ping Ng, Jennifer Tan, Glen Osbourne, Luke Williams, Mathias A.B. Bressel, Rodney J. Hicks, Eddie W.F. Lau, Julie Chu, Samuel Y.K. Ngan, Trevor Leong  Clinical and Translational Radiation Oncology  Volume 2, Pages 76-82 (February 2017) DOI: 10.1016/j.ctro.2017.01.008 Copyright © 2017 The Authors Terms and Conditions

Fig. 1 Study schema. Clinical and Translational Radiation Oncology 2017 2, 76-82DOI: (10.1016/j.ctro.2017.01.008) Copyright © 2017 The Authors Terms and Conditions

Fig. 2 Treatment plans comparison. Clinical and Translational Radiation Oncology 2017 2, 76-82DOI: (10.1016/j.ctro.2017.01.008) Copyright © 2017 The Authors Terms and Conditions

Fig. 3 Patients schema. Clinical and Translational Radiation Oncology 2017 2, 76-82DOI: (10.1016/j.ctro.2017.01.008) Copyright © 2017 The Authors Terms and Conditions

Fig. 4 Event plot. Clinical and Translational Radiation Oncology 2017 2, 76-82DOI: (10.1016/j.ctro.2017.01.008) Copyright © 2017 The Authors Terms and Conditions

Fig. 5 Overall survival, locoregional failure free and relapse free survival curves. Dashed lines represent 95% confidence intervals. Clinical and Translational Radiation Oncology 2017 2, 76-82DOI: (10.1016/j.ctro.2017.01.008) Copyright © 2017 The Authors Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.